EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men

Siresha Bathina iD, Mia Prado, Virginia Fuenmayor Lopez, Georgia Colleluori iD, Lina Aguirre, Rui Chen, Dennis T Villareal, Reina Armamento-Villareal iD

Biomolecules · 2025

DOI: 10.3390/biom15010079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Siresha Bathina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology Diabetes and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 1 Subunit, Testosterone, Transcription Factors, beta Catenin. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, NICHD NIH HHS, MIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously reported that PRDM16 mediated the improvement in body composition in testosterone (T)-treated hypogonadal men by shifting adipogenesis to myogenesis. Previous preclinical studies suggest that Prdm16 regulates Runx2, an important osteoblastic transcription factor, expression and activity. However, the changes in PRDM16, and other genes/proteins involved in osteoblastogenesis with T therapy in hypogonadal men are unexplored. We investigated the role of PRDM16 in RUNX2 activation by measuring changes in gene expression in peripheral blood monocytes (PBMCs) and proteins in the serum of hypogonadal men after T therapy for 6 months. Likewise, we evaluated changes in the WNT10b—β-CATENIN signaling pathway by gene expression and protein analyses. We found significant increases in PRDM16 and RUNX2 expression in PBMCs together with significant increases in serum proteins at 6 months when compared to baseline. There were also increases in gene and protein expressions of WNT10b, and β-CATENIN at 6 months. Furthermore, we found a significant positive correlation between % changes in PRDM16 and WNT10b. Our results suggest that T therapy activates PRDM16, leading to enhanced signaling in the canonical WNT10b—β-CATENIN-RUNX2 pathway, the pathway involved in osteoblastogenesis. The above findings may account for the improvement in bone density and quality in hypogonadal men treated with T.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Core Binding Factor Alpha 1 SubunitTestosteroneTranscription Factorsbeta CateninWnt ProteinsHypogonadismDNA-Binding ProteinsHumansMaleMiddle AgedOsteoblastsAdultOsteogenesisSignal TransductionProto-Oncogene Proteins

Stichwörter der Autor:innen

BMDPRDM16RUNX2osteoblastogenesis

Substanzen

Core Binding Factor Alpha 1 SubunitTestosteroneTranscription FactorsRUNX2 protein, humanbeta CateninWnt ProteinsWNT10B protein, humanDNA-Binding ProteinsPRDM16 protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • Division of Endocrinology Diabetes and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Medicine, Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston, TX 77030, USA.
  • Department of Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87107, USA.
  • Department of Medicine, New Mexico VA Health Care System, Albuquerque, NM 87107, USA.

ORCID-Profile: Siresha Bathina, Georgia Colleluori, Reina Armamento-Villareal

Förderung

  • CSRD VA
  • NICHD NIH HHS
  • MIH
  • VA merit Review

Zitieren

APA

Bathina, S., Prado, M., Fuenmayor Lopez, V., Colleluori, G., Aguirre, L., Chen, R., Villareal, D. T., & Armamento-Villareal, R. (2025). PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men. Biomolecules. https://doi.org/10.3390/biom15010079

Vancouver

Bathina S, Prado M, Fuenmayor Lopez V, Colleluori G, Aguirre L, Chen R, et al. PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men. Biomolecules. 2025. doi:10.3390/biom15010079

BibTeX
@article{Bathina2025,
  author = {Bathina, Siresha and Prado, Mia and Fuenmayor Lopez, Virginia and Colleluori, Georgia and Aguirre, Lina and Chen, Rui and Villareal, Dennis T and Armamento-Villareal, Reina},
  title = {PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15010079}
}
Kostenlos starten →